SLC5A5 and thyroid cancer: Together these findings demonstrate that the combination of CQ and SAHA enhances endogenous thyroidal NIS expression and function in vivo, highlighting the potential of pharmacologically inhibiting NIS endocytosis to increase therapeutic radionuclide uptake in patients with thyroid cancer.